InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Earnings radar
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-25)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

Bhaskara Rao Bollineni | Insider Transactions

← Executives ★ Sign in to follow

BR

Bhaskara Rao Bollineni

ININ·SEBI (PIT + SAST)

Krishna Institute of Medical Sciences Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the detailed record of transactions filed by Bhaskara Rao Bollineni. Officer active across 1 companies, notably Krishna Institute of Medical Sciences Limited. In total, 14 filings have been logged. The latest transaction was disclosed on 24 September 2024 (Pledge). Regulator: SEBI (PIT + SAST). The full history is accessible without signup.

Declarations14 total

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€4m670,000 shares@ €5.5812

Equity Shares

SEBI:f94858af578fa2b5609291f51189a841fe4936d5·24 Sept 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€779,80034,000 shares@ €22.9353

Equity Shares

SEBI:034951a3361c1401857cc39df3e850c6b94c69e9·14 Jun 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€2m103,000 shares@ €22.7126

Equity Shares

SEBI:dc79daa419f72a4b18ed457ea56b78da9782fc08·14 Jun 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€946,90042,000 shares@ €22.5452

Equity Shares

SEBI:a19a6de87b609485f8160f383d575d06d883b244·14 Jun 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€885,76042,000 shares@ €21.0895

Equity Shares

SEBI:89bc2031096e09d7c1cb1a1797b43e59a20a01fd·31 May 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€2m103,000 shares@ €20.4241

Equity Shares

SEBI:cd5637c30878afe7a3edad3647cdb4940b81f571·31 May 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€664,32034,000 shares@ €19.5388

Equity Shares

SEBI:67262e5c6df76a7082887652ed27d1e8c2d240a0·31 May 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€509,34620,000 shares@ €25.4673

Equity Shares

SEBI:0126e4374fce6931e705d1efd1429efce06c4117·27 Feb 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€2m96,000 shares@ €25.4673

Equity Shares

SEBI:77851b1732e1e4256790450df31c029551fcd069·28 Feb 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€2m76,000 shares@ €25.4673

Equity Shares

SEBI:b39f8ea236ad27f3a4bcfe230495a18b6676c9f4·27 Feb 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€726,50530,000 shares@ €24.2168

Equity Shares

SEBI:07c58bb556489e3a4487636fb5093bd695b6bfa3·13 Feb 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€3m144,000 shares@ €24.0616

Equity Shares

SEBI:67d1589e2097cd0a4c3c17496a4f179665ad68b4·13 Feb 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€5m224,000 shares@ €23.9507

Equity Shares

SEBI:58d68cb2ba567aec620e17ab4a38037e31fc9946·13 Feb 2024

Executives●PledgeKKrishna Institute of Medical Sciences Limited0SEBI

B

Bhaskara Rao Bollineni

€1m50,000 shares@ €24.5894

Equity Shares

SEBI:cb3b746481c572da8e15ba61f1058c11d6c81cfb·13 Feb 2024

14 of 14 declarations